Combining Anti-ERBB3 Antibodies Specific for Domain I and Domain III Enhances the Anti-Tumor Activity over the Individual Monoclonal Antibodies

por D’Souza, Jimson W., Reddy, Smitha, Goldsmith, Lisa E., Shchaveleva, Irina, Marks, James D., Litwin, Samuel, Robinson, Matthew K.
Publicado 2014

The Utility of Preoperative Vascular Grading in Patients Undergoing Surgery First for Pancreatic Cancer: Does Radiologic Arterial or Venous Involvement Predict Pathologic Margin St...

por Goel, Neha, D'Souza, Jimson W., Ruth, Karen J., Milestone, Barton, Karachristos, Andreas, Nagarathinam, Rajeswari, Cooper, Harry, Hoffman, John, Reddy, Sanjay
Publicado 2018

Safety and efficacy of letetresgene autoleucel alone or with pembrolizumab for relapsed/refractory multiple myeloma

por Nishihori, Taiga, Hoffman, James E., Huff, Anne, Kapoor, Gurpreet S., Eleftheriadou, Ioanna, Zajic, Stefan, Urbano, Alisa, Suchindran, Sunil, Chisamore, Michael, D’Souza, Jimson W., Faitg, Thomas, Rapoport, Aaron P.
Publicado 2022

Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatment

por Ye, Shuai, Sharipova, Dinara, Kozinova, Marya, Klug, Lilli, D’Souza, Jimson, Belinsky, Martin G., Johnson, Katherine J., Einarson, Margret B., Devarajan, Karthik, Zhou, Yan, Litwin, Samuel, Heinrich, Michael C., DeMatteo, Ronald, von Mehren, Margaret, Duncan, James S., Rink, Lori
Publicado 2021